Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudohallucinations associated with moclobemide: a case report.

D Degner1, S Kropp, J Porzig

  • 1Department of Psychiatry and Psychotherapy, Georg-August University of Göttingen, Germany. ddegner@gwdg.de

Pharmacopsychiatry
|July 19, 2005
PubMed
Summary

A patient experienced severe pseudohallucinations after starting moclobemide for depression. These adverse drug reactions resolved shortly after discontinuing the psychopharmacological medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2022
Same author

Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016.

The international journal of neuropsychopharmacology·2022
Same author

Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015.

European archives of psychiatry and clinical neuroscience·2021
Same author

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2020
Same author

[Psychopharmacotherapy during the COVID-19 pandemic].

Der Nervenarzt·2020

Area of Science:

  • Psychiatry
  • Pharmacovigilance
  • Neuroscience

Background:

  • The Arzneimittelsicherheit in der Psychiatrie (AMSP) project monitors adverse drug reactions (ADR) in psychopharmacology.
  • Understanding ADRs is crucial for patient safety in psychiatric treatment.

Observation:

  • A 23-year-old male patient with a depressive episode was treated with moclobemide.
  • Severe pseudohallucinations emerged six days after initiating moclobemide therapy.

Findings:

  • The patient's pseudohallucinations resolved within two days of discontinuing moclobemide.
  • This case highlights a potential adverse drug reaction associated with moclobemide treatment.

Implications:

  • The findings underscore the importance of monitoring for unusual neurological or perceptual adverse drug reactions.

Related Experiment Videos

  • Further investigation into the controversial nature of pseudohallucinations and their link to psychopharmacological agents is warranted.